1Eddy AA.Molecular basis of renal fibrosis[J].Pediatr Nephrol,2000,15(3-4):290-301.
2Liu Y.Renal fibrosis:new insights into the pathogenesis and therapeutics[J].Kidney Int,2006,69(2):213-217.
3Zeisberg M,Kalluri R.The role of epithelial-to-mesenchy-mal transition in renal fibrosis[J].J Mol Med,2004,82(3):175-181.
4Overduin M,Harvey T,Bagby S,et al.Solution structure of the epithelial cadherin domain responsiblefor selective cell adhesion[J].Science,1995,267(20):386-389.
5Hinck L,Nathke IS,Papkoff J,et al.Dynamics of cadherin/catenin complex formation:novel protein interactions and pathways of complex assembly[J].J Cell Biol,1994,125(6):1327-1340.
6Liu Y.Epithelial to mesenchymal transition in renal fibrogenesis:pathologic significance,molecularmechanism,and therapeutic intervention[J].J Am Soc Nephrol,2004,15(1):1-12.
5Sawada K, Mitra AK, Radjabi AR, etal. Loss of E - cadherin pro- motes ovarian cancer metastasis via ct5 -integrin,which is a thera-peutic target [ J ]. Cancer Res,2008,68 ( 7 ) :2329 - 2339.
6Bhagat R, Premalata CS, Shilpa V, et al. Altered expression of 13 - catenin, E - cadherin, and E - cadherin promoter methylation in ep- ithelial ovarian carcinoma [ J ]. Tumour Biol, 2013,34 (4) : 2459 - 2468.
7Arend RC, Londoeio - Joshi AI, Straughn Jr JM, et al. The Wnt/13 - catenin pathway in ovarian cancer: A review [ J ]. Gynecol Oncol, 2013,131(3):772 -779.
8Wang B, Liu SZ, Zheng RS et al. Time trends of ovarian cancer in- cidence in China[ J]. Asian Pacific J Cancer Prey,2014,15 ( 1 ) :191 - 193.
9Wakahashi S, Sudo T, Oka N, et al. VAV1 represses E - cadherin expression through the transactivation of Snail and Slug: A potential mechanism for aberrant epithelial to mesenchymal transition in hu- man epithelial ovarian cancer [ J ]. Translational Res, 2013,162 (3) :181 -190.
10Dreesen O, Brivanlou AH. Signaling pathways in cancer and em- bryonic stem cells[ J]. Stem Cell Rev,2007,3 (1):7 -17.
